All three deliver oestrogen — but the route of absorption, clot risk, hormone stability, and daily practicalities differ significantly. Here is what you need to know to choose.
June 2026 · 8 min read · Lambert Medical Clinical Team
One of the most common questions at a menopause consultation is: "Does it matter which form of HRT I take?" The short answer is yes — not in terms of whether HRT works, but in terms of safety profile, hormone level stability, convenience, and how your body absorbs it. Understanding the differences helps you have a more informed conversation with your GP and find the form that actually fits your life.
| Form | Route | Frequency | VTE Risk | Hormone Stability |
|---|---|---|---|---|
| Tablets | Oral (liver) | Daily | Increased | Moderate |
| Patches | Transdermal | Twice weekly | No increase | Good — steady release |
| Gel | Transdermal | Daily | No increase | Good — flexible dose |
| Spray | Transdermal | Daily | No increase | Good |
The key distinction in HRT is not gel versus patches — it is transdermal versus oral. Both gels and patches are transdermal: they deliver oestrogen through the skin directly into the bloodstream, completely bypassing the liver. Oral tablets, by contrast, are absorbed through the gut and must pass through the liver before entering the circulation. This first-pass hepatic metabolism changes everything.
When oestrogen passes through the liver (as it does with tablets), it stimulates the production of clotting factors. This is why oral HRT is associated with a small but real increased risk of venous thromboembolism (VTE) — deep vein thrombosis and pulmonary embolism. Multiple large studies confirm that transdermal HRT does not carry this risk. For most women this distinction is academic; for women with additional VTE risk factors, it is clinically important.
If any of these apply, transdermal is strongly preferred over tablets: BMI over 30 · personal or family history of DVT or pulmonary embolism · known thrombophilia (e.g. Factor V Leiden) · migraine with aura · active smoking · immobility or planned surgery. This is not a reason to avoid HRT — it is a reason to choose the safer route.
Patches contain oestrogen (and sometimes combined oestrogen + progestogen) in a reservoir or matrix that slowly releases hormone through the skin over 3–4 days. Most patches are changed twice weekly — the same days each week — and applied to the lower abdomen, buttock, or thigh.
Best for: Women who want a low-maintenance routine, dislike daily application, or are happy with combined oestrogen/progestogen in one product.
Oestrogen gel (such as Oestrogel or Sandrena) is applied daily to the skin of the arms, shoulders, or thighs and absorbed over the day. It comes in pump dispensers or individual sachets, which makes dose adjustment straightforward — your GP can increase or decrease the number of pumps without switching products.
Best for: Women who want flexibility in dose adjustment, have skin reactions to patches, or prefer a no-adhesive product.
Oral HRT tablets (such as Elleste, Femoston, or Evorel — though Evorel is actually a patch) are taken daily. Combined tablets containing both oestrogen and progestogen are available, or oestrogen-only tablets can be combined with a separate progestogen.
Best for: Low-risk women who prefer a simple pill format and have no VTE risk factors.
All women with a uterus who take oestrogen must also take progestogen to protect the uterine lining from endometrial hyperplasia and cancer. The type and form of progestogen matters too — and this is where the conversation often gets more nuanced.
Body-identical (micronised) progesterone — available as Utrogestan capsules — is associated with a more favourable cardiovascular profile and fewer side effects (mood, bloating, breast tenderness) than synthetic progestogens (progestins). Evidence from large observational studies suggests it also carries a lower breast cancer risk than older synthetic progestogens, though the absolute difference is small. It can be taken orally or used vaginally.
The combination of transdermal oestrogen (gel or patch) with body-identical progesterone (Utrogestan) is the form recommended by many menopause specialists as the safest overall option for most women — but it does require two separate products rather than one.
Our doctors will review your full medical history, risk profile, and preferences to recommend the HRT form and regimen that's right for you. We offer oestrogen gel, patches, and combined options, with follow-up at 3 months to review your response.
In terms of efficacy for hot flushes, night sweats, mood, sleep, and joint pain — all three forms are clinically equivalent when used at the appropriate dose. There is no evidence that one form works "faster" than another, though individual responses vary. Both patches and gel reach steady-state hormone levels within 1–2 weeks. Full symptom improvement typically takes 2–4 weeks, with maximum benefit at around 3 months.
What does differ is how stable hormone levels are. Oral tablets produce peaks after absorption and gradual troughs — some women notice this as variability in their symptoms through the day. Transdermal forms generally provide more stable hormone levels, which some women find translates to more consistent symptom control. If your symptoms feel erratic or inconsistent, switching from tablets to transdermal may help even at the same equivalent dose.
Private menopause and HRT review with an experienced GP. Blood tests, full history, and personalised prescription.
Book NowTransdermal (Gel / Patch)
No increased VTE (clot) risk. Preferred for most women, essential for those with risk factors.
Oral Tablets
Small increased VTE risk due to liver metabolism. Suitable for low-risk women without clot history.
Gels
Oestrogel · Sandrena · Estreva
Patches
Evorel · Estradot · FemSeven
Tablets
Elleste · Femoston · Kliofem
Progesterone
Utrogestan (body-identical micronised progesterone)